SLE: Treat-to-Target

Lupus Disease Activity Linked to High Autoantibody Levels Against PD-1, Study Shows

Read about a new study showing a correlation between autoantibodies against PD-1 with new-onset systemic lupus erythematosus.
lupusnewstoday.com

Existing damage, older age, index scores impact SLE organ damage progression, study finds

Many factors, such as existing organ damage, high damage index scores and older age, were…
healio.com

Remission in systemic lupus erythematosus: durable remission is rare

Introduction Remission is the ultimate goal in systemic lupus erythematosus (SLE). In this study, we applied four definitions of remission agreed on by an international…
ard.bmj.com

A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)

Objectives Treat-to-target recommendations have identified ‘remission’ as a target in systemic lupus erythematosus (SLE), but recognise that there is no universally accepted definition for this. Therefore, we initiated a process to achieve consensus on potential definitions for remission in SLE. Met…
ard.bmj.com